search

Active clinical trials for "Anemia"

Results 651-660 of 1566

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia...

Anemia

This is a randomized, double-blind, multicenter clinical phase III study involving about 105 cancer patients aged >18 years who are receiving palliative chemotherapy and who are suffering from chemotherapy associated anemia. A standard treatment group (ERYPO®) will be included to provide a reference reflecting current standard medical practice.

Completed34 enrollment criteria

A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis...

Anemia

This single arm study will assess the efficacy and safety of subcutaneous methoxy polyethylene glycol-epoetin beta (Mircera) for the correction and maintenance of hemoglobin levels in predialysis patients with renal anemia who are not currently treated with erythropoietin stimulating agents (ESA). Eligible patients will receive monthly subcutaneous injections of Mircera at an initial recommended dose of 1.2 micrograms/kg. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.

Completed7 enrollment criteria

Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants...

Renal Anemia

This sequential study will assess the efficacy and safety of multiple doses of intravenous (IV) methoxy polyethylene glycol-epoetin beta (MIRCERA), and will determine the optimum starting dose for maintenance treatment of anemia in children with chronic kidney disease on hemodialysis. Pediatric participants will remain on epoetin alfa, epoetin beta or darbepoetin alfa during the screening period, after which they will receive IV MIRCERA monthly, at a starting dose related to the previous weekly epoetin or darbepoetin alfa dose. Depending on the response achieved, another group may be selected to receive a higher or a lower dose.

Completed9 enrollment criteria

Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia

Anemia

The objective of this study is to evaluate the safety and tolerability of VIT-45 in the treatment of Iron Deficiency Anemia

Completed12 enrollment criteria

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron...

Anemia

The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent.

Completed13 enrollment criteria

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency...

Anemia

The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent.

Completed15 enrollment criteria

Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving...

AnemiaChronic Renal Failure1 more

The purpose of this study is to evaluate the safety and efficacy of peginesatide for the treatment of anemia in participants with chronic kidney disease who are on dialysis and are not taking any treatment to increase their red blood cell production.

Completed10 enrollment criteria

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney...

Anemia

The study will evaluate the safety and efficacy of a new intravenously administered iron drug to treat anemia in patients with chronic kidney disease who are not on dialysis.

Completed14 enrollment criteria

Peginesatide for Anemia in Chronic Hemodialysis Patients

AnemiaChronic Kidney Disease1 more

The purpose of this study is to evaluate the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of multiple intravenous doses of peginesatide in participants with chronic kidney disease (CKD) who are on hemodialysis.

Completed34 enrollment criteria

Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis...

Anemia

This is a open-label, prospective study comparing intravenous (IV) iron supplementation to standard care in anemic patents undergoing peritoneal dialysis.

Completed14 enrollment criteria
1...656667...157

Need Help? Contact our team!


We'll reach out to this number within 24 hrs